• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice.

作者信息

Bharadwaj Aditya S, Truesdell Alexander G, Lemor Alejandro, Thompson Julia B, Abu-Much Arsalan, Zhang Yiran, Schonning Michael J, Cohen David J, Lansky Alexandra J, O'Neill William W

机构信息

Division of Cardiology, Loma Linda University Medical Center, Loma Linda, California.

Inova Heart and Vascular Institute, Virginia Heart, Falls Church, Virginia.

出版信息

Am J Cardiol. 2024 Jul 1;222:8-10. doi: 10.1016/j.amjcard.2024.04.042. Epub 2024 Apr 27.

DOI:10.1016/j.amjcard.2024.04.042
PMID:38679222
Abstract
摘要

相似文献

1
Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice.当代美国实践中接受高风险经皮冠状动脉介入治疗患者的特征
Am J Cardiol. 2024 Jul 1;222:8-10. doi: 10.1016/j.amjcard.2024.04.042. Epub 2024 Apr 27.
2
Meta-Analysis of Prospective Studies of Risk stratification by Syntax Score for Unprotected Left Main Coronary Artery Revascularization.无保护左主干冠状动脉血运重建术Syntax评分风险分层前瞻性研究的Meta分析
Am J Cardiol. 2021 May 1;146:138-139. doi: 10.1016/j.amjcard.2021.02.003. Epub 2021 Feb 10.
3
Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance.医院层面经皮冠状动脉介入治疗表现与模拟风险规避
J Am Coll Cardiol. 2021 Nov 30;78(22):2213-2217. doi: 10.1016/j.jacc.2021.09.862.
4
Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial).经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干冠状动脉疾病患者出院静息心率对不良心血管结局的预测价值（来自 EXCEL 试验）。
Am J Cardiol. 2020 Jan 15;125(2):169-175. doi: 10.1016/j.amjcard.2019.10.004. Epub 2019 Oct 26.
5
Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative.当代美国无保护左主干冠状动脉经皮冠状动脉介入治疗的应用和趋势：国家心血管数据注册研究实践倡议分析。
JAMA Cardiol. 2019 Feb 1;4(2):100-109. doi: 10.1001/jamacardio.2018.4376.
6
Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.慢性阻塞性肺疾病对左主干冠状动脉疾病经皮冠状动脉介入治疗和旁路手术后预后的影响：来自 EXCEL 试验的分析。
Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1144-1151. doi: 10.1093/ejcts/ezy438.
7
Relation of Sex and Race to Outcomes in Patients Undergoing Percutaneous Intervention With Drug-Eluting Stents.经皮介入药物洗脱支架治疗患者的性别和种族与结局的关系。
Am J Cardiol. 2019 Mar 15;123(6):913-918. doi: 10.1016/j.amjcard.2018.12.021. Epub 2018 Dec 19.
8
Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.透析终末期肾病患者PCI期间药物洗脱支架与裸金属支架的比较
J Am Coll Cardiol. 2016 Mar 29;67(12):1459-1469. doi: 10.1016/j.jacc.2015.10.104.
9
Early discharge of patients (within 24 h) after percutaneous coronary intervention is feasible and safe in Indian setup.经皮冠状动脉介入治疗后 24 小时内提前出院（<24h）在印度环境中是可行且安全的。
Indian Heart J. 2020 Mar-Apr;72(2):126-127. doi: 10.1016/j.ihj.2020.03.014. Epub 2020 Apr 8.
10
Gender difference with the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: From pVAD Working Group.性别差异与使用经皮左心室辅助装置在接受复杂高危经皮冠状动脉介入治疗的患者中的应用：来自 pVAD 工作组。
Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):369-378. doi: 10.1177/2048872617745790. Epub 2018 Jan 8.

引用本文的文献

1
Characteristics and Outcomes of Older Patients Undergoing Protected Percutaneous Coronary Intervention With Impella.接受使用Impella进行的保护性经皮冠状动脉介入治疗的老年患者的特征与结局
J Am Heart Assoc. 2025 May 6;14(9):e038509. doi: 10.1161/JAHA.124.038509. Epub 2025 Apr 16.
2
Future Training Pathways in Percutaneous Coronary Interventions: Interventional Critical Care, Complex Coronary Interventions, and Interventional Heart Failure.经皮冠状动脉介入治疗的未来培训途径：介入重症监护、复杂冠状动脉介入治疗和介入性心力衰竭
JACC Adv. 2024 Oct 14;3(11):101338. doi: 10.1016/j.jacadv.2024.101338. eCollection 2024 Nov.